• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Celsion Corp. (CLSN)

    -NasdaqCM
    2.63 Down 0.17(6.07%) May 22, 3:59PM EDT
    Add to Portfolio
    Prev Close:2.80
    Open:2.80
    Bid:2.60 x 400
    Ask:2.71 x 300
    1y Target Est:7.33
    Beta:1.5
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:2.60 - 2.80
    52wk Range:2.15 - 3.73
    Volume:165,727
    Avg Vol (3m):261,006
    Market Cap:52.61M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLSN

    Comparison

    Symbol% ChgMkt Cap
    CLSNDown 6.07%52.61M
    BSDM 0.00%N/A
    DCTHUp 0.15%10.74M
    MMSIDown 1.79%890.97M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):111.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.24
    Quarterly EPS Est (Jun-15) :-0.35
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback